Fri, August 6, 2021

Maury Raycroft Downgraded (BCRX) to Hold on, Aug 6th, 2021

Maury Raycroft of Jefferies, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Hold on, Aug 6th, 2021.

Maury has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Maury's Rating of Hold.



This is the rating of the analyst that currently disagrees with Maury


  • Brian Cheng of "Cantor Fitzgerald" Initiated at Buy and Held Target at $21 on, Tuesday, August 3rd, 2021